-
1
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
-
2
-
-
47649102822
-
Aromatase inhibitors in ovarian cancer: Is there a role?
-
DOI 10.1111/j.1525-1438.2007.01075.x
-
Li YF, Hu W, Fu SQ, et al. Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer. 2008;18:600-614. (Pubitemid 352020164)
-
(2008)
International Journal of Gynecological Cancer
, vol.18
, Issue.4
, pp. 600-614
-
-
Li, Y.F.1
Hu, W.2
Fu, S.Q.3
Li, J.D.4
Liu, J.H.5
Kavanagh, J.J.6
-
3
-
-
34250708027
-
Antiestrogen therapy is active in selected ovarian cancer cases: The use of letrozole in estrogen receptor-positive patients
-
DOI 10.1158/1078-0432.CCR-06-2878
-
Smyth JF, Gourley C, Walker G, et al. Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients. Clin Cancer Res. 2007;13:3617-3622. (Pubitemid 46955124)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.12
, pp. 3617-3622
-
-
Smyth, J.F.1
Gourley, C.2
Walker, G.3
MacKean, M.J.4
Stevenson, A.5
Williams, A.R.W.6
Al, N.A.7
Rye, T.8
Rye, R.9
Stewart, M.10
McCurdy, J.11
Mano, M.12
Reed, N.13
McMahon, T.14
Vasey, P.15
Gabra, H.16
Langdon, S.P.17
-
4
-
-
36849019301
-
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic Oncology Group study
-
DOI 10.1200/JCO.2007.11.5345
-
Burger RA, Sill M, Monk BJ, et al. Phase II trial of bevacizumab in persistent or recurrent epithelial ovrian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2007;25:5165-5171. (Pubitemid 350237599)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.33
, pp. 5165-5171
-
-
Burger, R.A.1
Sill, M.W.2
Monk, B.J.3
Greer, B.E.4
Sorosky, J.I.5
-
5
-
-
37849035249
-
Phase II clinical trial of bevacizumab and low dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and Princess Margaret Hospital phase II consortia
-
Garcia AA, Hirte H, Fleming G, et al. Phase II clinical trial of bevacizumab and low dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. J Clin Oncol. 2008;26:76-82.
-
(2008)
J Clin Oncol
, vol.26
, pp. 76-82
-
-
Garcia, A.A.1
Hirte, H.2
Fleming, G.3
-
6
-
-
1642579678
-
Complementary and Alternative Therapies for Cancer
-
DOI 10.1634/theoncologist.9-1-80
-
Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004;9:80-89 (Pubitemid 38134016)
-
(2004)
Oncologist
, vol.9
, Issue.1
, pp. 80-89
-
-
Cassileth, B.R.1
Deng, G.2
-
7
-
-
0242352427
-
Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines
-
DOI 10.1016/j.ygyno.2003.07.004
-
Powell CB, Fung P, Jackson J, et al. Aqueous extract of herba Scutellaria barbatae, a Chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines. Gynecol Oncol. 2003;91:332-340. (Pubitemid 37346328)
-
(2003)
Gynecologic Oncology
, vol.91
, Issue.2
, pp. 332-340
-
-
Powell, C.B.1
Fung, P.2
Jackson, J.3
Dall'Era, J.4
Lewkowicz, D.5
Cohen, I.6
Smith-McCune, K.7
-
8
-
-
21044436266
-
11,11′-Dideoxy-verticillin: A natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity
-
DOI 10.1097/00001813-200506000-00007
-
Zhang YX, Chen Y, Guo XN, et al. 11,11′-Dideoxy-verticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity. Anticancer Drugs. 2005;16:515-524. (Pubitemid 40685736)
-
(2005)
Anti-Cancer Drugs
, vol.16
, Issue.5
, pp. 515-524
-
-
Zhang, Y.-X.1
Chen, Y.2
Guo, X.-N.3
Zhang, X.-W.4
Zhao, W.-M.5
Zhong, L.6
Zhou, J.7
Xi, Y.8
Lin, L.-P.9
Ding, J.10
-
9
-
-
0942269010
-
Five New Maleic and Succinic Acid Derivatives from the Mycelium of Antrodia camphorata and Their Cytotoxic Effects on LLC Tumor Cell Line
-
DOI 10.1021/np030293k
-
Nakamura N, Hirakawa A, Gao JJ, et al. Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J Natl Prod. 2004;67:46-48. (Pubitemid 38141309)
-
(2004)
Journal of Natural Products
, vol.67
, Issue.1
, pp. 46-48
-
-
Nakamura, N.1
Hirakawa, A.2
Gao, J.-J.3
Kakuda, H.4
Shiro, M.5
Komatsu, Y.6
Sheu, C.-C.7
Hattori, M.8
-
10
-
-
3843084006
-
Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells
-
Hseu YC, Yang HL, Lai YC, et al. Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells. Nutr Cancer. 2004;48:189-197.
-
(2004)
Nutr Cancer
, vol.48
, pp. 189-197
-
-
Hseu, Y.C.1
Yang, H.L.2
Lai, Y.C.3
-
11
-
-
33749241470
-
Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts
-
DOI 10.1016/j.canlet.2005.11.021, PII S0304383505010232
-
Peng CC, Chen KC, Peng RY, et al. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts. Cancer Lett. 2006;243:109-119. (Pubitemid 44485321)
-
(2006)
Cancer Letters
, vol.243
, Issue.1
, pp. 109-119
-
-
Peng, C.-C.1
Chen, K.-C.2
Peng, R.Y.3
Su, C.-H.4
Hsieh-Li, H.M.5
-
12
-
-
29844452617
-
Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata
-
Yang HL, Chen CS, Chang WH, et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett. 2006;231:215-227.
-
(2006)
Cancer Lett
, vol.231
, pp. 215-227
-
-
Yang, H.L.1
Chen, C.S.2
Chang, W.H.3
-
13
-
-
34247140126
-
Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata
-
Hseu YC, Chen SC, Tsai PC, et al. Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food Chem Toxicol. 2007;45:1107-1115.
-
(2007)
Food Chem Toxicol
, vol.45
, pp. 1107-1115
-
-
Hseu, Y.C.1
Chen, S.C.2
Tsai, P.C.3
-
14
-
-
15244358231
-
Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines
-
Hsu YL, Kuo YC, Kuo PL, et al. Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Lett. 2005;221:77-89.
-
(2005)
Cancer Lett
, vol.221
, pp. 77-89
-
-
Hsu, Y.L.1
Kuo, Y.C.2
Kuo, P.L.3
-
15
-
-
22544444405
-
Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture
-
Song TY, Hsu SL, Yen GC. Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture. J Ethnopharmacol. 2005;100:158-167.
-
(2005)
J Ethnopharmacol
, vol.100
, pp. 158-167
-
-
Song, T.Y.1
Hsu, S.L.2
Yen, G.C.3
-
16
-
-
22544440606
-
Mycelia from Antrodia camphorata in submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway
-
Song TY, Hsu SL, Yeh CT, et al. Mycelia from Antrodia camphorata in submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway. J Agric Food Chem. 2005;53:5559-5564.
-
(2005)
J Agric Food Chem
, vol.53
, pp. 5559-5564
-
-
Song, T.Y.1
Hsu, S.L.2
Yeh, C.T.3
-
17
-
-
34249888778
-
Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells
-
Chen KC, Peng CC, Peng RY, et al. Unique Formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells. Nutr Cancer. 2007;57:111-121. (Pubitemid 46871575)
-
(2007)
Nutrition and Cancer
, vol.57
, Issue.1
, pp. 111-121
-
-
Chen, K.-C.1
Peng, C.-C.2
Peng, R.Y.3
Su, C.-H.4
Chiang, H.-S.5
Yan, J.-H.6
Hsieh-Li, H.M.7
-
18
-
-
43249093771
-
Therapeutic targeting of death pathways in cancer: Mechanisms for activating cell death in cancer cells
-
Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. Adv Exp Med Biol. 2008;615:81-104.
-
(2008)
Adv Exp Med Biol
, vol.615
, pp. 81-104
-
-
Tan, T.T.1
White, E.2
-
20
-
-
62449284551
-
Bcl2 family proteins in carcinogenesis and the treatment of cancer
-
Frenzel A, Grespi F, Chmelewskij W, et al. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 2009;14:584-596.
-
(2009)
Apoptosis
, vol.14
, pp. 584-596
-
-
Frenzel, A.1
Grespi, F.2
Chmelewskij, W.3
-
21
-
-
0032511891
-
BAD partly reverses paclitaxel resistance in human ovarian cancer cells
-
Strobel T, Tai YT, Korsmeyer S, et al. BAD partly reverses paclitaxel resistance in human ovarian cancer cells. Oncogene. 1998;17:2419-2427. (Pubitemid 28544711)
-
(1998)
Oncogene
, vol.17
, Issue.19
, pp. 2419-2427
-
-
Strobel, T.1
Tai, Y.-T.2
Korsmeyer, S.3
Cannistra, S.A.4
-
22
-
-
18544367200
-
Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel
-
DOI 10.1074/jbc.M204042200
-
Mabuchi S, Ohmichi M, Kimura A, et al. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem. 2002;277:33490-33500. (Pubitemid 34984873)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.36
, pp. 33490-33500
-
-
Mabuchi, S.1
Ohmichi, M.2
Kimura, A.3
Hisamoto, K.4
Hayakawa, J.5
Nishio, Y.6
Adachi, K.7
Takahashi, K.8
Arimoto-Ishida, E.9
Nakatsuji, Y.10
Tasaka, K.11
Murata, Y.12
-
23
-
-
17644421083
-
Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy
-
DOI 10.1016/j.ccr.2005.02.008
-
Tan TT, Degenhardt K, Nelson DA, et al. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer cell. 2005;7:227-238. (Pubitemid 40568682)
-
(2005)
Cancer Cell
, vol.7
, Issue.3
, pp. 227-238
-
-
Tan, T.-T.1
Degenhardt, K.2
Nelson, D.A.3
Beaudoin, B.4
Nieves-Neira, W.5
Bouillet, P.6
Villunger, A.7
Adams, J.M.8
White, E.9
-
24
-
-
53249088373
-
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas
-
Sinicrope FA, Rego RL, Okumura K, et al. Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. Clin Cancer Res. 2008;14:5810-5818.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5810-5818
-
-
Sinicrope, F.A.1
Rego, R.L.2
Okumura, K.3
-
25
-
-
63949084962
-
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression
-
Liu H, Liang SL, Kumar S, et al. Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemother Pharmacol. 2009;63:997-1005.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 997-1005
-
-
Liu, H.1
Liang, S.L.2
Kumar, S.3
|